Off-Label Marketing Puts Novartis in Hot Water By ROSE BOUBOUSHIAN (CN) – Novartis Pharmaceuticals must face claims that it promoted the use on infants of a drug that U.S. regulators have deemed harmful, a federal judge ruled. While working as… Read More ›